Skip to content

Intentional Cell Activation Through Flexible Signaling

Easy to Implement. Designed to Translate.

Bead-free, modular immune cell signaling that lets scientists shape phenotype without reconfiguring workflows.

A NEW STARTING POINT FOR T CELL ACTIVATION​

Moving Beyond Fixed Activation​ ​

Most activation reagents are static by design. The signal identities, ratios, and surfaces are locked, leaving teams to adapt their cells to the reagent rather than the other way around.​

StimulusBio technology replaces fixed input with intentional design. Now, you can configure the cues your cells see in hours, instead of months.

Flexible Signaling

Molecule choice and spatial orientation is iterated to achieve performance-enhancing and phenotype-driven activation.

Simplified Workflow

Drop-in products enable the benefits of bead-free activation while also giving the flexibility to adapt to your unique workflow and feeder cells.

Built to
Translate

Activation conditions established during discovery carry forward into a run-ready process designed to lower costs and hands-on time.

Looking Ahead: Our Therapeutic Pipeline

StimulusBio is developing early-stage therapeutic concepts aligned with our core focus areas. Additional details will be shared as programs advance in 2026.

Industries We Serve

Therapeutic Developers

Discovery and translational teams shaping product-specific activation strategies & phenotype targets.

Process Development & CDMOs

Teams building scalable, run-ready expansion workflows.

Translational Immunologists

Researchers studying signal presentation and cell fate decisions.​

Tools Providers

Teams looking for an activation solution that fits their workflow without expensive instrument redesign.

Patient & Health Data IT

Improving patient care through data access.

Our strategy work supports clients to improve interoperability, accelerate diagnosis and give patients more control over their health.

Designed for product development, life science & biotech companies

Quantitative Precision Biology Drives
Better Patient Outcomes​

The StimulusBio science studio builds technologies that solve the life science industry’s greatest challenges: manufacturing efficiency, cost, and consistency

Our proprietary sbPCI technology that enables biologically-directed surface engineering, StimulusBio products aim to accelerate workflows, reduce variability, and expedite the delivery of life-saving treatments to patients.

sbPCI controls how immune cues are presented at the cell membrane using a biocompatible, lipid-bilayer base.​ The result is immune synapse-like control over the local signaling environment, configurable in hours rather than months, and applicable across activation and other cell–cell interaction designs.​

CellPilot Boost

Drop-in signaling for the cells you already use

  • Keep your current feeder or K562-based workflow
  • Add or swap costimulatory and cytokine signals quickly
  • Modify cells in under an hour, without re-engineering

CellPilot Expand

Bead-free activation as a complete reagent

  • Replace beads or feeder lines with a simpler workflow​
  • Combine activation and integrated cytokine delivery in one step​
  • Skip bead removal, isolation, and specialized equipment

CellPilot Custom

Phenotype-directed formulations, configured in 2–6 weeks​

  • Activate challenging cell types; NK, TIL, or non-
    standard populations​
  • Target a specific phenotype or functional profile​
  • Screen signal designs and carry the result into a run-ready format

What Our Clients Say

“Partnering with StimulusBio has been transformative. Their expertise in product development and commercialization helped us identify cell and gene therapy as an ideal target market. We were able to position ourselves as a leading innovator in this field by presenting data demonstrating how our technology solved relevant problems.”
“Having an external, expert perspective was invaluable. The StimulusBio team’s big-picture thinking and objectivity helped us see new possibilities.”
Confidential
CCO

Intelligent Product Strategy That
Drives Commercial Adoption​

The StimulusBio client services team helps life science teams shape products that meet market needs and support long-term growth. From proof-of-concept to launch, our commercial scientists guide decisions that keep development focused and aligned with business goals. 

We work closely with innovators through focused sessions and targeted consulting. The goal is simple: give you the insights and tools to make strong decisions at every step. 

 

We help teams see their product clearly: what works, what doesn’t, and what’s next.

Great products start with great people.

At StimulusBio, every team member brings deep scientific training and a sharp focus on product success. Whether working on market strategy or scientific development, our scientists apply proven methods and real-world insight to move ideas forward.

We combine commercial thinking with technical expertise to help life science products reach their full potential.